期刊文献+

217例胃肠间质瘤临床分析 被引量:14

Clinical analysis of 217 patients with gastrointestinal stromal tumor
原文传递
导出
摘要 目的探讨胃肠间质瘤(GIST)的临床特征、诊治及影响预后的因素。方法回顾性分析2005年1月至2010年9月华中科技大学同济医学院附属协和医院经手术治疗的217例GIST患者的临床病理资料。比较不同因素对患者预后的影响。结果217例患者中男性103例,女性114例,中位年龄55岁。除4例患者因广泛浸润未完整切除外,其余213例均行完整切除,其中35例行腹腔镜手术;48例术后EI服伊马替尼。178例(82.0%)患者获得术后随访,随访时间3。74个月。随访期间有16例(9.0%)发生术后复发和(或)转移,Logistic回归分析显示.肿瘤部位(OR=2.547,95%CI:1.466~4.424)和核分裂像(OR=6.556,95%CI:2.974。14.449)是影响根治术后复发和(或)转移的独立危险因素。随访患者中带瘤生存者5例,11例死于GIST,其中小肠GIST7例,肠道外GIST4例。Cox回归分析显示,核分裂像(RR=2.654,95%CI:1.094~6.438)与复发和(或)转移(RR=32.988,95%CI:3.879~280.529)是GIST患者的独立预后因素。结论肿瘤部位与核分裂像是影响GIST根治术后复发和(或)转移的独立因素,核分裂像与术后复发和(或)转移是影响GIST预后的独立因素。外科手术完整切除联合靶向治疗可使GIST患者获得满意疗效。 Objective To study the clinical characteristics, diagnosis, treatment and prognostic factors of gastrointestinal stromal tumor(GIST). Methods Clinicopathological data of 217 GIST patients from January 2005 to September 2010 in Wuhan Union Hospital were analyzed retrospectively and the prognostic factors were evaluated. Results There were 103 males and 114 females with a median age of 55 yeats old. Two hundred and thirteen patients underwent R0 resection and 4 R1 resection due to extensive invasion. Thirty-five patients underwent laparoscopic resection. Forty-eight patients received imatinib mesylate therapy after surgery. A total of 178 patients (82.0%) were followed up for 3 to 74 months. Sixteen patients (9.0%) developed recurrence or metastasis. Logistic regression analysis showed that tumor location (OR=2.547, 95% CI: 1.466-4.424) and mitotic count (OR=6.556, 95% CI: 2.974-14.449) were independent factors for post-operative recurrence or metastasis. Five patients survived with tumor, and 11 patients (6.2%) died of GIST including intestineal GIST (n=7) and extraintestinal GIST (n=4). Cox regression analysis showed that the mitotic count (RR=2.654, 95% CI: 1.094-6.438) and post-operative recurrence or metastasis (RR=32.988, 95% CI:3.879-280.529) were independent prognostic factors. Conclusions Tumor location and mitotic count are independent risk factors for post-operaive recurrence or metastasis in GIST. Mitotic count and post-operative recurrence or metastasis are independent indicators of poor prognosis. Surgical radical resection combined with targeted therapy can acheive satisfactory outcomes in patients with GIST.
出处 《中华胃肠外科杂志》 CAS 2012年第3期251-254,共4页 Chinese Journal of Gastrointestinal Surgery
关键词 胃肠间质瘤 治疗 外科手术 伊马替尼 Gastrointestinal stromal tumors Treatment Surgical procedures Imatinib
  • 相关文献

参考文献8

  • 1Fletcher CD, Berman JJ, Corless C, et al. Diagnosis of gastrointestinal stromal tumors: A consensus approach. Hum Pathol, 2002,33 (5) : 459-465.
  • 2Woodall CE, Brock GN, Fan J, et al. An evaluation of 2537 gastrointestinal stromal tumors for a proposed clinical staging system. Arch Surg, 2009,144(7) :670-678.
  • 3Bai J, Wang Y, Guo H, et al. Endoscopic resection of small gastrointestinal stromal tumors. Dig Dis Sci, 2010,55 (7): 1950-1954.
  • 4Novitsky YW, Kercher KW, Sing RF, et al.Long-term outcomes of laparoscopic resection of gastric gastrointestinal stromal tumors. Ann Surg, 2006,243(6):738-747.
  • 5胡伟国,马君俊,陆爱国,王明亮,李健文,臧璐,董峰,郑民华.腹腔镜手术治疗胃和小肠间质瘤[J].中华胃肠外科杂志,2007,10(1):35-38. 被引量:18
  • 6Parfitt JR, Streutker C J, Riddell RH, et al. Gastrointestinal stromal tumors: a contemporary review. Pathol Res Pract, 2006,202(12) : 837-847.
  • 7詹文华,王鹏志,邵永孚,伍晓汀,顾晋,李荣,万德森,丁克峰,师英强,于吉人,卢辉山,邹小明,毕建威,孙益红,陆云飞,陈道达,张信华.伊马替尼术后辅助治疗胃肠间质瘤的多中心前瞻性临床试验中期报告[J].中华胃肠外科杂志,2006,9(5):383-387. 被引量:87
  • 8张云,曹晖,汪明,沈丹平,沈志勇,倪醒之,吴志勇,沈艳莹,刘强.181例胃肠间质瘤的临床病理及预后分析[J].中华胃肠外科杂志,2009,12(2):150-154. 被引量:19

二级参考文献48

  • 1詹文华,王鹏志,邵永孚,伍晓汀,顾晋,李荣,万德森,丁克峰,师英强,于吉人,卢辉山,邹小明,毕建威,孙益红,陆云飞,陈道达,张信华.伊马替尼术后辅助治疗胃肠间质瘤的多中心前瞻性临床试验中期报告[J].中华胃肠外科杂志,2006,9(5):383-387. 被引量:87
  • 2张信华,何裕隆,詹文华,蔡世荣,张常华.胃肠间质瘤135例临床诊治分析[J].中华胃肠外科杂志,2007,10(1):17-20. 被引量:39
  • 3Fletcher CD, Beman JJ, Corless C, et al. Diagnosis of gastrointestinal stromal tumors: a consensus approach. Hum Pathol, 2002, 33(5):459-465.
  • 4Kamiyama Y, Aihara R, Nakabayashi T, et al. ^18F- fluorodeoxyglucose position emission tomography: useful technique for predicting malignant potential of gastrointestinal stromal tumors. World J Surg, 2005, 29(11) : 1429-1435.
  • 5Trent JC, Benjamin RS. New developments in gastrointestinal stromal tumor. Curr Opin Oncol, 2006, 18(4):386-395.
  • 6Miettinen M, Sobin LH, Lasota L. Gastrointestinal stromal tumors of stomach : a clinicopathologic, immunohistochemical, and molecular genetic study of 1765 cases with long-term follow-up. Am J Surg Pathol, 2005, 29(1 ) :52-68.
  • 7Heinrich MC, Corless CL, Duensing A, et al. PDGFRA activating mutations in gastrointestinal stromal tumors. Science, 2003, 299(5607) :708-710.
  • 8Gold JS, Dematteo RP. Combined surgical and molecular therapy: the gastrointestinal stromal tumor model. Ann Surg, 2006, 244(2) : 176-184.
  • 9Clary BM, DeMatteo RP, Lewis JJ, et al. Gastrointestinal stromal tumors and leiomyosarcoma of the abdomen and retroperitoneum: a clinical comparison. Ann Surg Oncol, 2001,8(4):290-299.
  • 10An JY, Choi MG, Noh JH, et al. Gastric GIST:a single institutional retrospective experience with surgical treatment for primary disease. Eur J Surg Oncol, 2007, 33(8) : 1030-1035.

共引文献120

同被引文献122

引证文献14

二级引证文献66

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部